Vanderbilt Health lands three of 35 Susan G. Komen research grants

Komen is the largest nonprofit funder of breast cancer research outside of the U.S. government, having invested more than $1.1 billion in research since its founding.

Improving Health Outcomes

New resources help people take action to prevent inherited diseases

To launch a connection search, someone with a specific gene variant signs up to meet others who share that variant, beginning a process of discovering new connections with unknown relatives and encouraging family members to get tested.

Three VUMC researchers receive Komen leadership grants

The grants support 25 cutting-edge projects at 17 institutions — marking a powerful commitment to improving outcomes for people living with breast cancer today and in the future.

Worldwide experts release clinical recommendations for management of ATM cancer risk 

Researchers established decades ago that ataxia-telangiectasia mutated (ATM) heterozygotes are at an increased risk for cancer, there remains a need to provide clear guidance for clinicians.

Study identifies that higher West African ancestry may contribute to worse breast cancer outcomes 

The study found that West African genetic ancestry was associated with shorter disease-free survival, particularly for women with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer.